SCHEMBL25553232

SCHEMBL25553232

COP(=O)(O)O[C@@H]1C(F)[C@H](C)O[C@@H]1COP(=O)(O)O[C@@H]1C(F)[C@H](C)O[C@@H]1COP(=O)(O)O[C@@H]1C(F)[C@H](C)O[C@@H]1C

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ FBP1 P09467 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13882147 0.92 FBP1 (0.30) FBP1
SCHEMBL25553231 0.89 — —
SCHEMBL25572011 0.86 — —
SCHEMBL12128761 0.81 FBP1 (0.33) FBP1
SCHEMBL13882144 0.80 FBP1 (0.31) FBP1
SCHEMBL13882141 0.80 FBP1 (0.33) FBP1
SCHEMBL24211073 0.78 — —
SCHEMBL20649715 0.78 — —
SCHEMBL21393146 0.78 — —
SCHEMBL13882148 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230158059-A1 PREKALLIKREIN-MODULATING COMPOSITIONS AND METHODS OF USE THEREOF ADARX PHARMACEUTICALS, INC. (US) 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230158059-A1 PREKALLIKREIN-MODULATING COMPOSITIONS AND METHODS OF USE THEREOF KLKB1, PRKG1, PRKCH FBP1 2074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback